New York City - Multinational pharmaceutical and biotechnology corporation Pfizer Inc. has announced plans to increase awareness of new medications and improve access for all Americans.
 |
| A Pfizer representative, shown here updating Arlene Borsky on a recently published study demonstrating the power of once-monthly griximumab for the treatment of primary grimp |
"Starting this Summer every American will be assigned their own pharmaceutical representative," Pfizer CEO Albert Bourla explained. "This personalizes our educational outreach and helps people connect with the medications that they might not even realize they need. It's about people, not our bottom line."
The "small pharma initiative", as the program is being called by industry leaders, is garnering praise from physicians. Some proponents, like family physician Mort Fishman, MD, are pleased that his patients will have access to more one-on-one guidance, particularly those who are members of the Pfizer subscription box service. "Their Pharm-to-Table service is an amazing way for people to try a variety of drugs, see what works, and simply return what they don't like. But that doesn't mean a little hand holding wouldn't be a good thing."
No comments:
Post a Comment